Fatigue and health-related quality of life in patients with immune thrombocytopenia: a longitudinal assessment in China

被引:0
作者
Zhang, Wenhui [1 ,2 ]
Xie, Shitong [3 ,4 ]
Fu, Rongfeng [1 ]
Chen, Yunfei [1 ]
Liu, Wei [1 ]
Sun, Ting [1 ]
Ju, Mankai [1 ]
Li, Huiyuan [1 ]
Xue, Feng [1 ]
Zhang, Lei [1 ]
Liu, Xiaofan [1 ,5 ,6 ]
Yang, Renchi [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Haihe Lab Cell Ecosyst, Natl Clin Res Ctr Blood Dis,State Key Lab Expt Hem, Tianjin, Peoples R China
[2] Qingdao Univ, Dept Hematol, Affiliated Hosp, Qingdao, Peoples R China
[3] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin, Peoples R China
[4] Tianjin Univ, Ctr Social Sci Survey & Data, Tianjin, Peoples R China
[5] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis,Haihe Lab Cell Ecosyst, Tianjin 300020, Peoples R China
[6] Tianjin Inst Hlth Sci, Tianjin 301600, Peoples R China
基金
中国国家自然科学基金;
关键词
Immune thrombocytopenia; HRQoL; FACIT-F; ITP-PAQ; longitudinal; PURPURA; MANAGEMENT; CANCER; ADULTS; COST;
D O I
10.1080/17474086.2023.2286730
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThere is lacking studies of longitudinally assessment of fatigue and health-related quality of life (HRQoL) among Chinese immune thrombocytopenia (ITP) adults. We aimed to evaluate changes in fatigue and HRQoL and identify the associated factors.MethodsPatients' characteristics, Functional Assessment of Chronic Illness Therapy (FACIT-F) and the ITP-specific Patient Assessment Questionnaire (ITP-PAQ) scores at admission (T0), at discharge (T1), and three months after discharge (T2) were collected. Linear mixed effects models were used to examine changes over time.ResultsWe included 175 patients. The mean score of FACIT-F at T0 was 37.2 and increased at T1 (39.0), while then decreased at T2 (34.7). Patients who were single, retired, had persistent ITP, splenomegaly had more severe fatigue, whereas those who had not received any prior treatment and had a bleeding score of 0 at admission had milder fatigue. The mean score of ITP-PAQ was 57.7 at T0, then gradually increased to 60.3 at T1 and 62.8 at T2. Patients with persistent ITP and those who have never received treatment for ITP have better HRQoL.ConclusionITP adults' fatigue and HRQoL were impaired. Patients' fatigue improved at discharge but worsened at three months after discharge, while HRQoL gradually improved over time.
引用
收藏
页码:1125 / 1133
页数:9
相关论文
共 33 条
  • [21] American Society of Hematology 2019 guidelines for immune thrombocytopenia
    Neunert, Cindy
    Terrell, Deirdra R.
    Arnold, Donald M.
    Buchanan, George
    Cines, Douglas B.
    Cooper, Nichola
    Cuker, Adam
    Despotovic, Jenny M.
    George, James N.
    Grace, Rachael F.
    Kuehne, Thomas
    Kuter, David J.
    Lim, Wendy
    McCrae, Keith R.
    Pruitt, Barbara
    Shimanek, Hayley
    Vesely, Sara K.
    [J]. BLOOD ADVANCES, 2019, 3 (23) : 3829 - 3866
  • [22] Fatigue in adult patients with primary immune thrombocytopenia
    Newton, Julia L.
    Reese, Jessica A.
    Watson, Shirley I.
    Vesely, Sara K.
    Bolton-Maggs, Paula H. B.
    George, James N.
    Terrell, Deirdra R.
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (05) : 420 - 429
  • [23] Updated international consensus report on the investigation and management of primary immune thrombocytopenia
    Provan, Drew
    Arnold, Donald M.
    Bussel, James B.
    Chong, Beng H.
    Cooper, Nichola
    Gernsheimer, Terry
    Ghanima, Waleed
    Godeau, Bertrand
    Jose Gonzalez-Lopez, Tomas
    Grainger, John
    Hou, Ming
    Kruse, Caroline
    McDonald, Vickie
    Michel, Marc
    Newland, Adrian C.
    Pavord, Sue
    Rodeghiero, Francesco
    Scully, Marie
    Tomiyama, Yoshiaki
    Wong, Raymond S.
    Zaja, Francesco
    Kuter, David J.
    [J]. BLOOD ADVANCES, 2019, 3 (22) : 3780 - 3817
  • [24] Health-related quality of life in adult primary immune thrombocytopenia
    Sestol, Hanna Gran
    Trangbaek, Sine Munch
    Bussel, James B.
    Frederiksen, Henrik
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (12) : 975 - 985
  • [25] Validation of the FACIT-fatigue subscale, selected items from FACT-thrombocytopenia, and the SF-36v2 in patients with chronic immune thrombocytopenia
    Signorovitch, James
    Brainsky, Andres
    Grotzinger, Kelly M.
    [J]. QUALITY OF LIFE RESEARCH, 2011, 20 (10) : 1737 - 1744
  • [26] Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey
    Snyder, Claire F.
    Mathias, Susan D.
    Cella, David
    Isitt, John J.
    Wu, Albert W.
    Young, Joan
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (10) : 2767 - 2776
  • [27] The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Properties, applications, and interpretation
    Kimberly Webster
    David Cella
    Kathleen Yost
    [J]. Health and Quality of Life Outcomes, 1 (1)
  • [28] Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, the Middle East, and Turkey: final analysis of CITE
    Wong, Raymond Siu Ming
    Yavasoglu, Irfan
    Yassin, Mohamed A.
    Tarkun, Pinar
    Yoon, Sung -Soo
    Wei, Xie
    Elghandour, Ashraf
    Angchaisuksiri, Pantep
    Ozcan, Mehmet
    Yang, Renchi
    Mattar, Mervat
    Rahman, Masiur
    Ingles, Sara
    Goldbrunner, Michael
    Frueh, Jennifer A.
    Jang, Jun Ho
    [J]. BLOOD ADVANCES, 2023, 7 (17) : 4773 - 4781
  • [29] Health-Related Quality of Life and Burden of Fatigue in Chinese Patients with Immune Thrombocytopenia: A Cross-Sectional Study
    Yang, Ran
    Yao, Hao
    Lin, Lin
    Ji, Jian-min
    Shen, Qun
    [J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2020, 36 (01) : 104 - 111
  • [30] Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system
    Yellen, SB
    Cella, DF
    Webster, K
    Blendowski, C
    Kaplan, E
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 13 (02) : 63 - 74